Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM-AD: Vitamin E and Memantine in Alzheimer's Disease
NCT00235716Phase 3Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Aug 2007
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of memantine and alpha-tocopherol in Alzheimer's disease (AD) (4 arms), sponsored by United States Department of Veterans Affairs. Primary endpoint: Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory at 48 months. Started Aug 2007; status: completed.
02
Drugs
memantinealpha-tocopherol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00235716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235716.